- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 251/18 - Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom with nitrogen atoms directly attached to the two other ring carbon atoms, e.g. guanamines
Patent holdings for IPC class C07D 251/18
Total number of patents in this class: 183
10-year publication summary
|
10
|
27
|
8
|
14
|
9
|
8
|
11
|
5
|
11
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Servier Pharmaceuticals, LLC | 102 |
17 |
| BASF SE | 20432 |
14 |
| Agios Pharmaceuticals, Inc | 211 |
7 |
| Emory University | 1588 |
7 |
| Anji Pharmaceuticals Inc. | 37 |
7 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 670 |
6 |
| Pfizer Inc. | 3368 |
5 |
| Centaurus Biopharma Co., Ltd. | 84 |
5 |
| Lianyungang Runzhong Pharmaceutical Co., Ltd. | 86 |
5 |
| Luoda Biosciences, Inc. | 6 |
4 |
| Aluda Pharmaceuticals, Inc. | 4 |
4 |
| Bayer Cropscience AG | 2138 |
3 |
| Takeda Pharmaceutical Company Limited | 2943 |
3 |
| Minoryx Therapeutics S.L. | 47 |
3 |
| The United States Government AS represented by The Department of Veterans Affairs | 1097 |
3 |
| University of Basel | 43 |
3 |
| AstraZeneca AB | 2958 |
2 |
| Centre National de La Recherche Scientifique | 10102 |
2 |
| Astellas Pharma Inc. | 1125 |
2 |
| Betta Pharmaceuticals Co., Ltd. | 175 |
2 |
| Other owners | 79 |